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Abstract
The insulin -23Hph and IGF2 Apa polymorphisms were genotyped in Romanian patients with T1DM (n = 204), T2DM
(n = 215) or obesity (n = 200) and normoponderal healthy subjects (n = 750). The genotypes of both polymorphisms
were distributed in concordance with Hardy-Weinberg equilibrium in all groups. The -23Hph AA genotype increased
the risk for T1DM (OR: 3.22, 95%CI: 2.09-4.98, p < 0,0001), especially in patients without macroalbuminuria (OR:
4.32, 95%CI: 2.54-7.45, p < 0,0001). No other significant association between the alleles or genotypes of insulin
-23Hph and IGF2 Apa and diabetes or obesity was identified.
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Introduction
Insulin and IGF2 (11p15.5) are candidate genes for
complex traits, including type I diabetes mellitus (T1DM)
(Owerbach and Gabbay, 1994), type II diabetes mellitus
(T2DM) (Huxtable et al., 2000) and obesity with onset es-
pecially in childhood and middle-age (O’Dell et al., 1999;
Le Stunff et al., 2001; Gu et al., 2002; Roth et al., 2002;
Heude et al., 2004). It is very difficult to determine the real
marker(s)forsusceptibilitytothesecomplextraits,because
many polymorphisms from this region of chromosome 11
are in strong linkage disequilibrium with each other. As a
consequence, several functional polymorphisms from the
insulin – IGF2 region have been frequently implicated with
diabetes and/or obesity in association or linkage based
studies. One of these is a VNTR polymorphism located in
the insulin promoter, 596 bp upstream of the insulin start
codon. Some of its variants may adopt noncanonical con-
formations that can be recognized by trans regulator fac-
tors, like Pur-1/MAZ. The Insulin -23HphI and IGF2 Apa
are other polymorphisms that have recently received atten-
tion (Barratt et al., 2004; Marchand and Polychronakos,
2007), because they may interfere with gene expression
(Vafiadis et al., 1998; Kralovicova et al., 2006) and predis-
position to some pathologic traits (O’Dell et al., 1997,
1999; Gaunt et al., 2001).
In this study we tested the possible association be-
tween two polymorphisms from the insulin – IGF2 region
and T1DM, T2DM and obesity.
Subjects and Methods
Subjects
A total of 1369 unrelated Romanian Caucasians (682
men, 687 women), older than 18 years, was enrolled in the
study. Patients with T1DM (n = 204), T2DM (n = 215) or
obesity (n = 200) diagnosed for at least two years were se-
lected from the N Paulescu Institute (Bucharest, Romania).
T1DM patients were selected if they were younger than 20
yearsattheonsetofthedisease,requireddailyinsulintreat-
ment and had a BMI between 18.5-25 kg/m
2. T2DM pa-
tients were included if they had had more than two fasting
glycemia values above 140 mg/dL after the age of 30 years
old,aBMIof18.5-30kg/m
2andrequirednotreatmentwith
insulin. Obese patients were selected based on BMI values
between 30-40 kg/m
2 and glycemia in a fasting state
 110 mg/dL. The presence or absence of hypertension
(blood pressure above 130/85 mm Hg or treatment with
antihypertensivemedication),smoking(morethanfivecig-
arettes per day, for at least one year) and drinking (at least
25gofalcoholperday,foratleastoneyear)habitswerere-
corded for all participants.
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Research ArticleThe control subjects comprised a total of 750 individ-
uals (381 men, 369 women) selected from visitors attend-
ing two medical clinics from Bucharest for routine
checking. They were matched for age, sex, ethnicity and
birth place with patients and were equally distributed into
Hc1, Hc2 and Hc3 groups. All normal individuals had no
relatives with DM, obesity or other genetic syndromes.
Informed consent was obtained from all subjects be-
fore enrolment. The design of the study was in accordance
with internationally agreed ethical standards (Declaration
ofHelsinki,1964)andapprovedbytheNPaulescuhospital
ethical committee.
Laboratory procedures
Fasting plasma glucose, serum total cholesterol, se-
rum triglycerides and HbA1C levels were measured using
standard laboratory protocols. Genomic DNA was isolated
using a commercial kit (Wizard Genomic DNA Purifica-
tionKit,Promega)fromvenousblood(1mL)collectedinto
tubes containing EDTA. Genotyping for insulin -23Hph
(-23A/T,rs689)andIGF2Apa(820G/A,rs680)wasbased
on a RFLP method. The INSF 5’tccaggacaggctgcatcag3’,
INSR 5’agcaatgggcggttggctca3’ and IGF2F
5’cttggactttgagtcaaattgg3’,IGF2R5’cctcctttggtcttactggg3’
primer pairs (Sigma Genosys) were used for PCR (Corbett
Research thermocycler). Amplicons (5 L) were electro-
phoresed on agarose gel (2%) after digestion with6Uo f
HphIo rApaI endonucleases (New England BioLabs). Two
researchers who did not know the clinical data of the sub-
jects independently scored all genotypes. Ten percent of
randomly selected samples were re-genotyped as a quality
control. No errors in genotyping were observed.
Statistical analysis
After checking the normality of distribution for con-
tinuous variables by means of the Shapiro-Wilk W test,
comparisons of these parameters between groups were per-
formed through Mann-Whitney U non-parametric tests.
Categorical variables between groups were compared
through chi-squared tests, that were also used for verifying
genotype departures from Hardy-Weinberg equilibrium
within each group and for comparing genotype frequencies
between affected and control subjects. Odds ratio (ORs)
andtheircorresponding95%confidenceintervalswerecal-
culated for estimating disease risks corresponding to geno-
types AA from -23Hph and IGF2Apa. All statistical
analysesandprocedureswereperformedusingcommercial
software (STATSDirect version 2.6.4).
Results
The main characteristics of the patients and controls
are presented in Table 1. Patients with T2DM (52.41  7.21)
were older than those with T1DM (33.01  6.23,
p < 0.0001) or obesity (43.39  11.16, p < 0.0001). The
BMI and triglycerides levels were higher in T2DM and
obese patients compared with Hc2 and Hc3 controls
(p < 0.0001). The T2DM patients are more often smokers
than control subjects (p = 0.0001). Macroalbuminuria was
significantly (Yate’s corrected chi2 = 4.54, p = 0.03) more
frequent in T1DM (28.92%, M/F: 27/32) than in T2DM
(19.53%,M/F:19/23).Theoccurrenceofhypertensionwas
similar in all groups of patients (~50%).
The distribution of the -23Hph and IGF2 Apa geno-
types were in Hardy-Weinberg equilibrium in all groups
(Table 2). The Insulin -23Hph (chi
2 = 0.84, DF = 4,
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Table 1 - Clinical and biochemical data of subjects selected for this study.
Parameters T1DM Hc1 T2DM Hc2 Ob Hc3
Number 204 250 215 250 200 250
Gender (M/F) (
c) 105/99 142/108 114/101 135/115 82/118 104/146
Age (in years): Mean  SD
(range)
33.01  6.23
(21-53)
33.4  6.42
(21-53)
52.41  7.21
(31-65)
52.58  7.04
(31-65)
43.39  11.16
(20-64)
44.3  11.32
(20-64)
p (patients vs. Hc)
mw 0.55 0.83 0.4
Current BMI (kg/m
2)M SD
(range)
23.03  1.42
(18.9-24.98)
23.12  1.28
(18.98-24.95)
24.78  2.37
(19.35-29.98)
23.00  1.4
(18.98-24.95)
34.87  2.33
(30.03-39.9)
22.99  1.44
(18.9-24.98)
p (patients vs. Hc)
mw 0.73 < 0.0001 < 0.0001
HbA1C (%) 8.6  1.8 nd 8.1  2.1 nd 4.8  0.4 nd
Fasting plasma glucose (mg/dL) nd 88  9 110  15 86  11 92  88 4  10
Total cholesterol  SD (mg/dL) 179.2  43.3 157.3  31.4 206.8  39.5 138.6  25.2 217.4  50.2 165.1  37.4
Triglycerides  SD (mg/dL) 112.1  24.84
(62-210)
109.96  16.73
(61-157)
121.71  20.63
(75-211)
106.6  19.92
(61-196)
159.62  69.7
(53-484)
109.82  22.42
(65-198)
p (patients vs. Hc)
mw 0.9501 < 0.0001 < 0.0001
Smokers (
c) 25 31 57 p < 0.0001 21 21 26
Drinkers (
c) 2 32 93 12 42 63 5p = 0.93) and IGF2 Apa (chi
2 = 5.78, DF = 4, p = 0.22) ge-
notypes are similar in the control lots, Hc1, Hc2 and Hc3.
We observed a different distribution of -23Hph genotypes
inT1DMandHc1lots.The-23HphAAgenotypeissignifi-
cantly associated with T1DM (OR: 3.22, 95% CI: 2.09-
4.98, p < 0.0001). This genotype remains also more fre-
quent in T1DM than in controls (89.66% vs. 50.26%) if pa-
tients with macroalbuminuria and their matched controls
were excluded from the analysis. In this case, the associa-
tionbetweenAAgenotypeandT1DMincreases(OR:4.32,
95% CI: 2.54-7.45, p < 0.0001). The disease risk remains
non-significant if the T2DM patients with macroalbumi-
nuriaandtheirmatchedcontrolswereexcludedfromanaly-
sis.
We did not observe any other significant associations
between investigated markers and clinical and biochemical
data (e.g. age of disease onset, sex).
Discussion
This is the first study to simultaneously assess the re-
lationship between insulin – IGF2 polymorphisms and
T1DM, T2DM and obesity in the Romanian population.
Previous studies in other countries have shown that poly-
morphisms from the insulin – IGF2 region can predispose
to some complex pathological traits, particularly those in-
volving diabetes. Several functional polymorphisms or an
extended haplotype may represent the genetic bases for
these observations. We conducted a case-control study to
investigatetherelationshipbetweentheinsulin-23Hphand
IGF2 Apa polymorphisms and three common pathological
phenotypes: T1DM, T2DM and obesity. Association stud-
ies can identify substantial genetic effects (e.g. OR > 2.0)
between normal and clinical phenotypes using relatively
small sample sizes (n = 200) (Dupont and Plummer, 1990).
The subjects were selected from an ethnically homogenous
populationsurroundingBucharesttoavoidspuriousassoci-
ations.
The variants of Insulin -23Hph (-23Hph A: 73.53%)
and IGF2 Apa (IGF2 A: 77.3%) polymorphisms in our
healthy controls are similar to those reported for Cauca-
sians (Bennett and Todd, 1996).
We found a strong association between insulin
-23Hph polymorphism and T1DM (ORAA = OR: 3.22, 95%
CI: 2.09-4.98, p < 0.0001). This result is in agreement with
previous studies based on Caucasian cohorts (Undlien et
al.,1994;Krokowskietal.,1997)orfamilies(Daviesetal.,
1994) which also showed the importance of markers from
this region regarding diabetes susceptibility. As a common
observation the results of these studies support the impor-
tance of markers in linkage disequilibrium with class I
VNTR disequilibrium on the risk for T1DM.
In our study 59 patients with T1DM and 37 patients
with T2DM have proteinuria. The frequency of the AA ge-
notype in T1DM lot (81.37% vs. 50.26%) and the disease
risk (ORAA: 4.32, 95% CI: 2.54-7.45) increases when pa-
tients with macroalbuminuria and their matched controls
were excluded from analyses. We did not identify a similar
effect in patients with T2DM. The -23Hph A allele is in al-
most complete linkage disequilibrium with the INS VNTR
class I. It has been previously reported that the prevalence
of proteinuria in insulin-requiring diabetic patients is sig-
nificantly higher in homozygotes for INS VNTR class I
variants than in carriers of other genotypes (Raffel et al.,
1991). Additional studies are necessary to clarify these dis-
cordant results.
The genetic background (Wilkin, 2009), body mass
(Kibirigeetal.,2003;Bettsetal.,2005;Knerretal.,2005),
different degree of immune activation (Hathout et al.,
2001; Umpaichitra et al., 2002) and insulin resistance seem
to represent some common reference points in the complex
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Table 2 - Genotypes and alleles distributions of the examined polymorphisms in each studied group.
Genotype T1DM Hc1 T2DM Hc2 Ob Hc3
-23Hph AA 158 129 118 131 107 131
-23Hph AT 40 109 89 104 85 108
-23Hph TT 6 12 8 15 8 11
A%:T% 87.25: 12.75 73.4:26.6 75.58: 24.42 73.2:26.8 74.75:25.25 74:26
HW 2.86 3.4 3.17 0.91 3.17 3.76
Chi2 32.56, p < 0.0001 1.35, p = 0.509 0.08, p = 0.9607
ORAA (95%CI) 3.22 (2.10-4.98) 1.11 (0.75-1.62) 1.05 (0.71-1.54)
IGF2 Apa GG 127 139 117 152 115 156
IGF2 Apa GA 69 102 76 85 71 79
IGF2 Apa AA 8 9 22 13 14 15
G%:A% 79.17: 20.83 76: 24 72.1:27.9 77.8:22.2 75.25:24.75 78.2:21.8
HW 0.13 3.51 3.17 0.06 0.44 1.34
Chi2 2.33, p = 0.31 4.76, p = 0.09 1.12, p = 0.57
ORAA (95%CI) 1.32 (0.89-1.96) 0.77 (0.52-1.13) 0.82 (0.55-1.21)relationships between T1DM, T2DM and obesity. For this
study, we carefully selected nonobese diabetic patients and
nondiabeticobesepatientsinanattempttoreducetheeffect
of factors which may link these phenotypes. The Insulin
-23Hph polymorphism was similarly distributed in T2DM
and Hc2 lots (p > 0.05) irrespective of the degree of renal
involvement. Similar results have been reported in some
(e.g. Pima Indians), but not all populations (Ong et al.,
1999; Lindsay et al., 2003).
We did not observe a significant association between
-23Hph genotypes and obesity in middle aged patients
(p > 0.05). This result is in agreement with other studies, in
which IDDM2 markers were also found to not change the
risk for obesity in middle-aged subjects (Sandhu et al.,
2005). A similar distribution of IGF2 Apa in patients and
controls was observed in our lots. Although the IGF2 poly-
morphisms were also not associated with BMI in mid-
dle-aged subjects in other population (Heude et al., 2007),
it is speculated that an extended haplotype may better de-
scribetherelationshipbetweenobesityandresponsetoglu-
cose at least in older men (Rodríguez et al., 2006). In our
study the results were non-significant even when the gen-
der was taken into account (p > 0.05).
Apredispositionfordiabetesandobesitymaybetrig-
gered by genetic and environmental determinants of
growth patterns from prenatal to childhood life (Stene et
al., 2001; EURODIAB Substudy 2 Study Group, 2002).
We cannot entirely exclude the insulin and IGF2 genes as
candidates for these complex traits because data regarding
the origin of risk alleles, birth size and postnatal growth de-
velopment were not available for this study. The contribu-
tion of polymorphisms from this region to predisposition
for human pathology will be much better understood after
testing of additional genetic (e.g. cis or trans factors,
epigenetic modifications) and non-genetic (e.g. maternal
factors, intracellular environment) factors.
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